CBIO Other | CRESCENT BIOPHARMA, INC.

CRESCENT BIOPHARMA, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2025-05-14: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · GLYC · NASDAQ.
2025-02-13: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · GLYC · NASDAQ.
2024-11-13: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · GLYC · NASDAQ.
2024-08-08: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.001 par value · GLYC · NASDAQ.

Filed	Form	Item	As filed
2025-05-14	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2025-02-13	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2024-11-13	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2024-08-08	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2024-05-09	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2024-03-27	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2023-11-03	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2023-08-02	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2023-05-03	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2023-03-29	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2022-11-09	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2022-08-03	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2022-04-28	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2022-03-03	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2021-11-02	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2021-08-05	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2021-05-03	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2021-03-02	10-K	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2020-11-06	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2020-07-31	10-Q	Stock registered under Section 12(b)	Common Stock, $0.001 par value · GLYC · NASDAQ
2019-11-07	10-Q	Emerging growth company	Yes
2019-08-01	10-Q	Emerging growth company	Yes
2019-05-02	10-Q	Emerging growth company	Yes
2019-03-06	10-K	Emerging growth company	Yes
2018-11-02	10-Q	Emerging growth company	Yes

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
ARVINAS, INC. (ARVN)	United States	$0.510B	58.38
PUMA BIOTECHNOLOGY, INC. (PBYI)	United States	$0.507B	15.53
CAPRICOR THERAPEUTICS, INC. (CAPR)	United States	$0.499B	-10.81
Ovid Therapeutics Inc. (OVID)	United States	$0.487B	-14.41
Phathom Pharmaceuticals, Inc. (PHAT)	United States	$0.572B	-8.76
ASSEMBLY BIOSCIENCES, INC. (ASMB)	United States	$0.481B	-13,053.96
Altimmune, Inc. (ALT)	United States	$0.593B	-6.43
Monopar Therapeutics (MNPR)	United States	$0.598B	-34.82